Work

Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

Year: 2017

Type: article

Study design: Observational Study

Source: Cell Host & Microbe

DOI: 10.1016/j.chom.2017.03.003

Authors: Leopoldo N. Segal, Jose C. Clemente, Yonghua Li, Chunhai Ruan, Jane Cao, Mauricio Danckers, Alison Morris, Sarah Tapyrik, Benjamin G. Wu, Philip Diaz, Gregory Calligaro, Rodney Dawson, Richard N. van Zyl-Smit, Keertan Dheda, William N. Rom, Michael D. Weiden

Institutions: New York University, Icahn School of Medicine at Mount Sinai, University of Michigan, Michigan Medicine, University of Pittsburgh, The Ohio State University, University of Cape Town

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: NYU Lung Cancer Biomarker Center, HIV activation in secondary pulmonary infection, Michigan Regional Comprehensive Metabolomics Resource Core (MRC2), Smoking cessation and the natural history of HIV-associated emphysema, Institutional Clinical and Translational Science Award, Longtitudinal Studies of HIV-Associated Bacterial Pneumonia, HIV/TB Interaction in the Lung, Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease, Lung Microbiome and Inflammation in Early COPD, Longitudinal evaluation of HIV-associated lung disease phenotypes, Clinical and Translational Science Award, Cancer Center Support Grant, NYR-Diabetes Research Center (NYR-DRC)

OpenAlex ID: W2602210733

FWCI: 7.458

Cites: 50

Cited by: 156

Related to: 10